VDP-106 [Governance] Proposal eligibility criteria to enter the VitaDAO deal-flow funnel
|
|
29
|
1901
|
July 6, 2023
|
Public Good Index
|
|
0
|
208
|
July 5, 2023
|
Ambassador Program Progress
|
|
0
|
286
|
July 5, 2023
|
VDP-110: Allocating Resources for the Next Batch of VitaDAO Longevity Fellows
|
|
0
|
487
|
July 5, 2023
|
Newbie Perspective
|
|
13
|
906
|
July 4, 2023
|
VDP-104 [Governance]: Amendment to VDP-100 (Fractionalization of Newcastle-Korolchuk)
|
|
7
|
453
|
June 30, 2023
|
VDP 107 [Governance] - Dealflow Steward Restructuring & Network Steward Preparation
|
|
9
|
963
|
June 30, 2023
|
VDP-93 [Governance]: Proposal to Revise Governance Workflow
|
|
22
|
1085
|
July 19, 2023
|
VDP-102 [Governance]: Portfolio Management Process
|
|
14
|
1011
|
July 19, 2023
|
Season 0 Announcement
|
|
0
|
400
|
February 22, 2023
|
VDP-99: Bridging VITA to Optimism, Arbitrum and Polygon
|
|
7
|
769
|
May 29, 2023
|
VDP-100 (Fractionalization of Newcastle-Korolchuk IP-NFT)
|
|
22
|
1805
|
May 24, 2023
|
VDP-101 Proposal to Establish an Operating Entity for VitaDAO
|
|
12
|
1110
|
June 9, 2023
|
VDP-91: TelomEYE
|
|
5
|
646
|
May 24, 2023
|
VDP-94 Proposal to Reallocate VITA Tokens
|
|
4
|
1010
|
April 26, 2023
|
VDP-97 [Governance]: $VITA allocations for community & awareness contributors
|
|
3
|
782
|
May 2, 2023
|
VDP-XX Arginine Opal Suppressor tRNA for Age-Related Diseases
|
|
4
|
764
|
May 13, 2023
|
Metagovernance Framework Amendments
|
|
15
|
420
|
April 21, 2023
|
VDP-80 [Assessment]: ImmuneAGE
|
|
14
|
1443
|
April 5, 2023
|
VDP-72 Proposal to Approve the Compensation Policy for 2023
|
|
22
|
2093
|
March 27, 2023
|
SG 0.3c - Creating VitaTech - a US-based NewCo to obtain government funding for longevity research
|
|
20
|
1111
|
March 29, 2023
|
SG 0.1a - Ambassador Program
|
|
26
|
1553
|
March 29, 2023
|
SG 0.3a - Commercialization Squad
|
|
16
|
1561
|
March 29, 2023
|
SG 0.3b - Molecule Dealflow and Development Services
|
|
3
|
909
|
March 29, 2023
|
Decentrilized trusted social network Exodus 2.0 http://exodus2.tilda.ws/shorten
|
|
2
|
253
|
April 4, 2023
|
Governance Squad Weekly Sync (3rd Apr)
|
|
0
|
275
|
April 3, 2023
|
VDP-63 Anticancer and pro-longevity effects of high molecular weight hyaluronic acid (from naked mole rat to human) - Vera Gorbunova
|
|
18
|
2004
|
March 24, 2023
|
VDP-87 [Assessment] Zoe Biosciences
|
|
1
|
928
|
March 24, 2023
|
G 0.1c (revised) - Onboarding videos for Strategic Goal - Increase Community Size v2
|
|
2
|
305
|
April 1, 2023
|
General Self Introduction
|
|
0
|
274
|
March 30, 2023
|